Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Journal of UOEH|March 15, 2016
[Factors Associated with Diagnostic Yield of Endobronchial Ultrasonography with a Guide Sheath for Peripheral Lung Cancer]Keigo Uchimura, Kei Yamasaki, Hiroshi Ishimoto, et al.Microbiology and Immunology|December 19, 2008
Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-specific CTL epitopeZheyu Li, Yoshihiro Oka, Akihiro Tsuboi, et al.International Journal of Hematology|January 15, 2008
Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myelomaAkihiro Tsuboi, Yoshihiro Oka, Hiroko Nakajima, et al.Nature|February 9, 2018
Enhancer redundancy provides phenotypic robustness in mammalian developmentMarco Osterwalder, Iros Barozzi, Virginie Tissières, et al.Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysisMark M Awad, Giulia C Leonardi, Sasha Kravets, et al.Nature Communications|October 6, 2016
Genome-wide compendium and functional assessment of in vivo heart enhancersDiane E Dickel, Iros Barozzi, Yiwen Zhu, et al.Cell|January 24, 2018
Ultraconserved Enhancers Are Required for Normal DevelopmentDiane E Dickel, Athena R Ypsilanti, Ramón Pla, et al.Nature Methods|August 2, 2020
Supervised enhancer prediction with epigenetic pattern recognition and targeted validationAnurag Sethi, Mengting Gu, Emrah Gumusgoz, et al.Cell Reports|September 21, 2022
Genome-wide fetalization of enhancer architecture in heart diseaseCailyn H Spurrell, Iros Barozzi, Michael Kosicki, et al.Nature Communications|October 10, 2024
A gene desert required for regulatory control of pleiotropic Shox2 expression and embryonic survivalSamuel Abassah-Oppong, Matteo Zoia, Brandon J Mannion, et al.Pageof 6